Showing results (131-140 of 228) with videos related to

Sort By:
Pageof 23
Arteriosclerosis, Thrombosis, and Vascular Biology|August 27, 2005
Value of high-density lipoprotein (HDL) subpopulations in predicting recurrent cardiovascular events in the Veterans Affairs HDL Intervention TrialBela F Asztalos, Dorothea Collins, L Adrienne Cupples, et al.
The American Journal of Cardiology|February 24, 2007
Comparison of the effects of high doses of rosuvastatin versus atorvastatin on the subpopulations of high-density lipoproteinsBela F Asztalos, Florence Le Maulf, Gerald E Dallal, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2006
Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium scoreAlexandra Mangili, Jul Gerrior, Alice M Tang, et al.
The American Journal of Cardiology|January 25, 2011
Effects of maximal atorvastatin and rosuvastatin treatment on markers of glucose homeostasis and inflammationNuntakorn Thongtang, Masumi Ai, Seiko Otokozawa, et al.
The American Journal of Cardiology|December 31, 2003
Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjectsErnst J Schaefer, Judith R McNamara, Timothy Tayler, et al.
Obesity Research|December 25, 2003
Obesity modulates the association among APOE genotype, insulin, and glucose in menRoberto Elosua, Serkalem Demissie, L Adrienne Cupples, et al.
The American Journal of Cardiology|October 3, 2002
Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjectsErnst J Schaefer, Judith R McNamara, Timothy Tayler, et al.
Atherosclerosis|October 14, 2005
The L162V polymorphism at the peroxisome proliferator activated receptor alpha locus modulates the risk of cardiovascular events associated with insulin resistance and diabetes mellitus: the Veterans Affairs HDL Intervention Trial (VA-HIT)E Shyong Tai, Dorothea Collins, Sander J Robins, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|March 15, 2003
Change in alpha1 HDL concentration predicts progression in coronary artery stenosisBela F Asztalos, Marcelo Batista, Katalin V Horvath, et al.
Archives of Internal Medicine|December 3, 2002
Diabetes, plasma insulin, and cardiovascular disease: subgroup analysis from the Department of Veterans Affairs high-density lipoprotein intervention trial (VA-HIT)Hanna Bloomfield Rubins, Sander J Robins, Dorothea Collins, et al.
Pageof 23